from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1702c/-

LFCtreatmentdescriptionclass of inhibitor

-0.647

Amikacinug/mL Amikacintranslation

-0.691

Cap5-10ug/mL Capreomycintranslation

-0.503

Rox10-50 ug/mL Roxithromycintranslation

-0.745

SM2-5 ug/mL Streptomycintranslation

-1.079

Tet5-10 ug/mL Tetracyclinetranslation

-0.247

Rif0.2-5ug/mL Rifampicintranscription

-0.353

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.687

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.405

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.398

CPZ10-50 ug/mL Chlorpromazinerespiration

1.004

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.266

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.692

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.305

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.098

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.283

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.270

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.224

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.030

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.435

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.373

KCN5-20 ug/mL Potassium cyaniderespiration

-0.522

NaN30.2-2 mM Sodium aziderespiration

0.745

Nigericin50 uM Nigericinrespiration

0.976

TRC10-150 ug/mL Triclosanrespiration

0.263

TRZ10-25 ug/mL Thioridazinerespiration

0.017

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.310

menadione6-10 ug/mL Menadionerespiration

-0.275

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.931

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.759

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.509

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.650

NRP_1Non-replicating persistence stage 1dosRassociated

-0.376

Amp0.2mg/mL AmpicillincellWall

-0.480

Cephalexin20-100 ug/mL CephalexincellWall

-0.400

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.265

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.028

EMB10-20 ug/mL EthambutolcellWall

-0.702

Eta12-40 ug/mL EthionamidecellWall

-0.807

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.685

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.553

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.377

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.052

BZA0.12 mg/mL BenzamidearomaticAmides

0.011

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.052

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.409

H2O24 mM hydrogen peroxideDNAdamaging

3.383

Levo10 ug/mL LevofloxacinDNAdamaging

0.384

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.792

Novobiocin10 ug/mL NovobiocinDNAdamaging

2.448

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.888

UVUV-irradiationDNAdamaging

-0.444

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.313

Antimycin12.5-50 ug/mL Antimycin A?

-0.234

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.481

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.480

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.682

PA8240.2-2 ug/mL PA-824?

-0.055

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.316

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.341

Verapamil50 uM Verapamil?

-0.379

mercaptoethanol2 mM 2-Mercaptoethanol?

0.038

methoxatin10-20 ug/mL Methoxatin?